# Seroquel XR in Adults With Schizophrenia

> **NCT00852631** · PHASE3 · TERMINATED · sponsor: **AstraZeneca** · enrollment: 28 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Quetiapine fumarate (Seroquel)

## Key facts

- **NCT ID:** NCT00852631
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** The study was prematurely terminated due to insufficient recruitment.
- **Last updated:** 2012-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00852631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00852631, "Seroquel XR in Adults With Schizophrenia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00852631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*